05-Aug-2026
Download PDF
Fredun Pharma
In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Un-Audited Financial Results of the Company for the quarter ended 30th June 2026 along with the Limited Review Report as issued by M/s. R.H. Nisar & Co Statutory Auditor of the Company
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
